Outcomes of extracorporeal membrane oxygenation in influenza versus COVID ‐19 during the first wave of COVID‐19
ConclusionsCOVID-19 patients who were treated in our institution with VV-ECMO had statistically lower ECMO survival rates than influenza patients. It is possible that COVID-19 immunomodulation therapies may increase the risk of other superimposed infections.
Source: Journal of Cardiac Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Cameron M. Blazoski,
Michael Baram,
Qiong Yang,
Hitoshi Hirose Tags: ORIGINAL ARTICLE Source Type: research
More News: Bacterial Pneumonia | Cardiovascular & Thoracic Surgery | Coronavirus | COVID-19 | Influenza | Pneumonia | Respiratory Medicine | SARS | Statistics | Study